228. 閉塞性細気管支炎 Bronchiolitis obliterans Clinical trials / Disease details

臨床試験数 : 96 / 薬物数 : 125 - (DrugBank : 34) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 155

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00141726 (ClinicalTrials.gov)	October 2003	30/8/2005	Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant	Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study	Lung Injury, Acute;Respiratory Distress Syndrome, Adult;Bronchiolitis Obliterans	Drug: Etanercept	University of Michigan Cancer Center	NULL	Completed	6 Years	N/A	All	34	Phase 2	United States
2	NCT00029328 (ClinicalTrials.gov)	September 2001	10/1/2002	Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation	Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation	Respiratory Distress Syndrome, Adult;Bronchiolitis Obliterans;Pneumonia	Drug: etanercept	FDA Office of Orphan Products Development	NULL	Completed	12 Months	N/A	Both	15	Phase 1/Phase 2	United States